
Overview
Dr. William E. Fisher is Professor and Vice-Chair for Clinical Affairs, Department of Surgery and the George L. Jordan, M.D. Chair in General Surgery at Baylor College of Medicine. Dr. Fisher also serves as Director of the Elkins Pancreas Center at BCM; and is Vice President, Medical Staff and Chief of the Surgery Service Line at Baylor St. Luke’s Medical Center.An internationally-known leader in pancreatic surgery, Dr. Fisher has focused entirely on surgery for pancreatic tumors and cysts in his practice for over 20 years and has extensive experience in advanced, minimally-invasive robotic pancreas surgery.Dr. Fisher’s professional interests include: pancreaticoduodenectomy (Whipple procedure); minimally invasive/laparoscopic/robotic pancreatic surgery; pancreas cancer; distal and central pancreatectomy; pancreas resection; surgical oncology; common bile duct resection; Puestow procedure; Frey procedure; and laparoscopic pancreatectomy.Dr. Fisher has served as PI of two NIH-funded multicenter randomized clinical trials that generated practice-changing impact on the use of drains during pancreatectomy, and the subsequent development of a multicenter pancreatic-surgery-outcomes consortium. His basic science lab has studied the influence of gastrointestinal hormones on pancreatic cancer growth, the relationship between diabetes and pancreatic cancer, and genomic analysis of pancreatic cancer, resulting in over 160 peer-reviewed publications.Having served as principal investigator on more than 15 clinical trials for patients with pancreatic cancer, Dr. Fisher is currently PI at BCM for the NIH Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer.Dr. Fisher received a B.A. from Wittenberg University and earned his medical degree from the University of Cincinnati College of Medicine. He held a research fellowship and completed his residency at The Ohio State University.Among his numerous honors and awards, Dr. Fisher has been recognized as one of America’s Top Doctors for Cancer (Castle Connolly Medical Ltd.), Top 1% of Doctors in the U.S. (U.S. News and World Report), and “Texas Super Doctor” (Texas Monthly). He is also the recipient of the Master Clinician Award for Excellence in Patient Care from BCM and has twice received the DeBakey Distinguished Service Award from the Michael E. DeBakey Department of Surgery at BCM.
Dr. Fisher is rated as a Distinguished provider by MediFind in the treatment of Hereditary Pancreatitis. His top areas of expertise are Chronic Pancreatitis, Pancreatic Cancer, Hereditary Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy.
His clinical research consists of co-authoring 162 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 31 articles in the study of Hereditary Pancreatitis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UT Physicians
Tien Ko is a General Surgeon in Houston, Texas. Dr. Ko is rated as a Distinguished provider by MediFind in the treatment of Hereditary Pancreatitis. His top areas of expertise are Hernia, Hereditary Pancreatitis, Acute Pancreatitis, Gallbladder Removal, and Fasciotomy. Dr. Ko is currently accepting new patients.
Dr. Omar Barakat is a general surgeon specializing in benign and malignant diseases of the liver, bile duct, gallbladder, and pancreas. He is an Associate Professor of Surgery - Division of Surgical Oncology at Baylor College of Medicine and Medical Director of the Neuroendocrine Tumor Program at Baylor St. Luke’s Medical Center.Dr. Barakat’s clinical interests include: malignant hepatobiliary and pancreatic diseases, liver and pancreas surgery; upper gastrointestinal surgery; neuroendocrine tumors; gastrointestinal stromal tumors (GIST); and minimally invasive surgery.Dr. Barakat has developed new surgical techniques to minimize the complication rate and blood loss following pancreatic and liver surgeries. He utilizes image-guided therapies, such as radiofrequency ablation, microwave ablation, irreversible electroporation (NanoKnife system), trans-arterial chemotherapy, and selective internal radiotherapy (SIRT) with Yttrium-90 microspheres, to treat liver tumors while minimizing trauma to the patients. Dr. Barakat's clinical and research interests also include the study of neuroendocrine tumors; and the development of off-the-shelf bio-artificial liver organs that can be suitable for liver transplantation in patients with end-stage liver disease.Dr. Barakat received his medical degree from Aleppo University Medical School in Aleppo, Syria. He completed a residency in general surgery at the Medical College of Pennsylvania, Episcopal Hospital in Philadelphia and a Fellowship in cardiovascular surgery research at State University of New York - Buffalo. He also completed clinical fellowships in liver transplantation at The University of Texas Health Science Center in Houston; and in heart transplantation and mechanical assist devices aat the Texas Heart Institute. He continued his practice in liver and pancreatic surgery at Freeman Hospital in Newcastle Upon-Tyne, United Kingdom, where he treated complex and rare tumors of the liver, bile duct, and pancreas. Dr. Barakat is board-certified by the Royal College of Surgeons (Ed), United Kingdom, where he is also a Fellow. Dr. Barakat is rated as an Advanced provider by MediFind in the treatment of Hereditary Pancreatitis. His top areas of expertise are Chronic Pancreatitis, Gallbladder Disease, Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.
Cypress Surgical PLLC
Ata Ahmad is a General Surgeon in Houston, Texas. Dr. Ahmad is rated as a Distinguished provider by MediFind in the treatment of Hereditary Pancreatitis. His top areas of expertise are Gallbladder Disease, Cholecystitis, Gallstones, Hernia Surgery, and Gastrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic PancreatitisDr. Fisher isElite. Learn about Chronic Pancreatitis.
- Pancreatic CancerDr. Fisher isElite. Learn about Pancreatic Cancer.
- PancreaticoduodenectomyDr. Fisher isElite. Learn about Pancreaticoduodenectomy.
- Distinguished
- Childhood PancreatitisDr. Fisher isDistinguished. Learn about Childhood Pancreatitis.
- Familial Pancreatic CancerDr. Fisher isDistinguished. Learn about Familial Pancreatic Cancer.
- Hereditary PancreatitisDr. Fisher isDistinguished. Learn about Hereditary Pancreatitis.
- PancreatectomyDr. Fisher isDistinguished. Learn about Pancreatectomy.
- Pancreatic Ductal AdenocarcinomaDr. Fisher isDistinguished. Learn about Pancreatic Ductal Adenocarcinoma.
- Advanced
- Acute PancreatitisDr. Fisher isAdvanced. Learn about Acute Pancreatitis.
- Ampullary CancerDr. Fisher isAdvanced. Learn about Ampullary Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)
- Esophageal CancerDr. Fisher isAdvanced. Learn about Esophageal Cancer.
- Gastrointestinal FistulaDr. Fisher isAdvanced. Learn about Gastrointestinal Fistula.
- GlucagonomaDr. Fisher isAdvanced. Learn about Glucagonoma.
- Experienced
- Bile Duct StrictureDr. Fisher isExperienced. Learn about Bile Duct Stricture.
- Biliary HypoplasiaDr. Fisher isExperienced. Learn about Biliary Hypoplasia.
- CholestasisDr. Fisher isExperienced. Learn about Cholestasis.
- EndoscopyDr. Fisher isExperienced. Learn about Endoscopy.
- Gallbladder AdenocarcinomaDr. Fisher isExperienced. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Fisher isExperienced. Learn about Gallbladder Cancer.
